1. KL-6, IL-17 与 CTD-ILD 的相关性研究.
- Author
-
刘兴许, 李梅华, 任朝凤, 王蔚平, 李丽, 柏媛, 张春梅, 蒋菁, 郑章敏, and 周冬玉
- Abstract
Objective To compare the expression levels of KL-6 and IL-17 in CTD-ILD and CTD,to explore the diagnostic value of KL-6 and IL-17 in CTD-ILD,and to analyze the correlation between KL-6 and IL17 and pulmonary diffusion function, provide a basis for the diagnosis and severity assessment of CTD-ILD. Methods Patients who visited Kunming First People's Hospital between September 1,2022,and January 31, 2024,were selected. A total of 30 patients with connective tissue diseases combined with interstitial lung disease were collected for the experimental group,referred to as the CTD-ILD group. 39 patients with connective tissue diseases were collected for the control group,referred to as the CTD group. The ELISA double-sandwich antibody method was used to detect KL-6 and IL-17, and correlation analysis was performed on the collected data. Results (1) Serum KL-6 and IL-17 levels in the CTD-ILD group were higher than those in the CTD group,and the difference was statistically significant ( P < 0.05) . ( 2) There is a negative correlation between KL-6 and DLCO%pred,while there is no correlation between IL-17 and DLCO%pred(P < 0.05). (3) The receiver operating characteristic curve (ROC) analysis showed that the AUC for KL-6 and IL-17 in diagnosing CTD-ILD were 0.902 and 0.656,respectively. Conclusion KL-6 and IL-17 can serve as indicators for diagnosing CTD-ILD,with KL6 having a higher diagnostic value than IL-17. KL-6 can be used to assess the severity of lung diffusion function,while IL-17 is not suitable for evaluating the severity of lung diffusion function. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF